據報小米等14款國產AI大模型獲新一輪備案 擬即日起開放服務
據內媒報道,內地新一輪國產AI大模型備案批准已經下發,涉及14款大模型,分別來自13家內地AI公司。
14款大模型包括小米-W(01810.HK)的「小愛同學AI助手」新功能、早前已公布通過備案第四範式(06682.HK)的「式說」大模型、銜遠科技的「品商」和「摹小仙」大模型及BOSS直聘的「南北閣」大模型等。
銜遠科技昨日(25日)通過其公眾號發布「品商」和「摹小仙」兩款大模型已獲批。而部分大模型產品和功能已從即日起面向全社會開放服務。(ta/cy)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.